Skip to Main Content

Paper Details

Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors.
J Immunother Cancer
14
2022
Author NameAffiliation
Philippe L BedardUniversity Health Network, Princess Margaret Cancer Centre
  • 1 - 1

Datasets

Release 1.2